Real-world evidence can be used to show that a drug or medical device is safe and effective. The FDA has […]
A pharma-led R Studio webinar last week tackled the topic of designing effective data visualizations that can both provide better […]
For the past number of years artificial intelligence (AI) and machine learning (ML) have been subject to almost unbridled optimism, […]
Following the COVID-19 outbreak, which caused unprecedented disruption to the running of clinical trials, there has been an increasing interest […]
The transformation currently underway within pharma organizations is undoubtedly driving the need for, and use of, real-world data and evidence. […]
AI explainability is one of the most discussed topics when it comes to applying AI in healthcare. Here, we summarise […]
“The pandemic has brought out a lot of good, bad, and ugly.” – Cynthia Girman, Pharmaceutical Executive, Merck (on the […]
We summarise a recent article, published in Cell, that explored the benefits and challenges of using real-world evidence (RWE) in […]
A new study, published as a preprint in BMC Medical Informatics and Decision Making, has described a framework to generate […]
A recent debate article, published in BMC Geriatrics, has explored whether artificial intelligence (AI) health monitoring may be a suitable […]
